SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Strategies & Market Trends : The Epic American Credit and Bond Bubble Laboratory -- Ignore unavailable to you. Want to Upgrade?


To: Elroy Jetson who wrote (43076)10/8/2005 3:15:39 PM
From: CalculatedRisk  Read Replies (3) | Respond to of 110194
 
"Tamiflu can suppress H5N1 at the beginning of infection, but it isn't a cure. It must be taken at the right time or it's ineffective. It also has not been approved for use in children. And in some adults, it may only partly suppress the virus, leaving them ambulatory carriers of infection. On top of that, the latest scientific studies indicate that some H5N1 viruses may already be resistant to the drug."

Is that paragraph correct?

latimes.com